CA3137691A1 - Novel pharmaceutical composition - Google Patents

Novel pharmaceutical composition Download PDF

Info

Publication number
CA3137691A1
CA3137691A1 CA3137691A CA3137691A CA3137691A1 CA 3137691 A1 CA3137691 A1 CA 3137691A1 CA 3137691 A CA3137691 A CA 3137691A CA 3137691 A CA3137691 A CA 3137691A CA 3137691 A1 CA3137691 A1 CA 3137691A1
Authority
CA
Canada
Prior art keywords
citric acid
administration
pharmaceutical composition
anemia
weeks
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3137691A
Other languages
English (en)
French (fr)
Inventor
Michiaki Abe
Seizo Koshiba
Koichiro Nishioka
Kazuhiko Kawaguchi
Satomi Yamasaki
Yasuyuki Teranaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tohoku University NUC
Nippon Chemiphar Co Ltd
Original Assignee
Tohoku University NUC
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tohoku University NUC, Nippon Chemiphar Co Ltd filed Critical Tohoku University NUC
Publication of CA3137691A1 publication Critical patent/CA3137691A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3137691A 2019-04-28 2020-04-24 Novel pharmaceutical composition Pending CA3137691A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2019086945 2019-04-28
JP2019-086945 2019-04-28
JP2019119297 2019-06-27
JP2019-119297 2019-06-27
PCT/JP2020/017690 WO2020222302A1 (ja) 2019-04-28 2020-04-24 新規医薬組成物

Publications (1)

Publication Number Publication Date
CA3137691A1 true CA3137691A1 (en) 2020-11-05

Family

ID=73028960

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3137691A Pending CA3137691A1 (en) 2019-04-28 2020-04-24 Novel pharmaceutical composition

Country Status (7)

Country Link
US (1) US20220202752A1 (https=)
EP (1) EP3964264A4 (https=)
JP (1) JPWO2020222302A1 (https=)
KR (1) KR20220004643A (https=)
AU (1) AU2020267068A1 (https=)
CA (1) CA3137691A1 (https=)
WO (1) WO2020222302A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7219898B2 (ja) * 2017-04-18 2023-02-09 国立大学法人東北大学 アルカリ性化剤による血液浄化

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4722492B2 (ja) * 2005-01-11 2011-07-13 日本メナード化粧品株式会社 鉄欠乏性貧血に伴う不定愁訴の予防又は改善剤。
JP2009525277A (ja) * 2006-01-30 2009-07-09 グロボアジア エルエルシー 軟組織石灰化の回復、予防、遅延または安定化方法
EP2194977A1 (en) * 2007-08-31 2010-06-16 C.B. Fleet Company Incorporated Method of preventing nephrocalcinosis
MX357998B (es) * 2015-03-20 2018-07-11 Antonio Hernandez Miramontes Jorge Una mezcla de acidos carboxilicos, especificamente acido citrico, acido succinico, acido fumarico y acido malico para el tratamiento de pacientes con insuficiencia renal cronica, insuficiencia renal aguda, hepatopatias agudas o cronicas que cursen con hiperamonemia, enfermedades congenitas con alteraciones enzimaticas en el ciclo de la urea, asi como condiciones clínicas que cursen con balance nitrogenado negativo.
CA3010771A1 (en) * 2016-01-06 2017-07-13 Rockwell Medical, Inc. Combination therapy with an iron compound and a citrate compound
WO2018193648A1 (ja) 2017-04-18 2018-10-25 国立大学法人東北大学 アルカリ性化剤による血液浄化
JP7578234B2 (ja) * 2017-04-18 2024-11-06 国立大学法人東北大学 アルカリ性化剤による血液浄化
JP6296410B1 (ja) 2017-11-06 2018-03-20 株式会社ＤａｔａＳｉｇｎ 利用サービス管理装置
JP6810683B2 (ja) 2017-12-28 2021-01-06 本田技研工業株式会社 制御装置および車両
AU2019361520B2 (en) * 2018-10-17 2025-04-24 Nippon Chemiphar Co., Ltd. Novel pharmaceutical composition

Also Published As

Publication number Publication date
AU2020267068A1 (en) 2021-11-18
EP3964264A4 (en) 2023-07-12
KR20220004643A (ko) 2022-01-11
EP3964264A1 (en) 2022-03-09
US20220202752A1 (en) 2022-06-30
JPWO2020222302A1 (https=) 2020-11-05
WO2020222302A1 (ja) 2020-11-05

Similar Documents

Publication Publication Date Title
US12324793B2 (en) Method for renal protection
KR102773144B1 (ko) 시트르산의 의약적으로 허용 가능한 염, 혹은 그 수화물 또는 그들의 혼합물을 포함하는 의약 조성물
JP2023115271A (ja) アルカリ性化剤による血液浄化
CN106413706A (zh) 三麦芽酚铁的剂量方案
JP2026063342A (ja) 腎機能保護剤
CA3137691A1 (en) Novel pharmaceutical composition
CA3116695A1 (en) Inhibitor of renal fibrosis in diabetic nephropathy
EP4338731A1 (en) Composition for increasing muscle mass
HK40056055A (en) Novel pharmaceutical composition
RU2741426C1 (ru) Никотинамид для лечения дислипидемии
TW202547454A (zh) 治療前的尿白蛋白濃度在特定範圍之慢性腎臟病的治療用醫藥組成物
HK40079287A (en) Renal function protectant
US20210353575A1 (en) Agent for suppressing alcohol sickness or hangover due to alcoholic beverage ingestion
HK40015305A (en) Nicotinamide for treating dyslipidemia

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20240312

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20250507

B12 Application deemed to be withdrawn, abandoned or lapsed

Free format text: ST27 STATUS EVENT CODE: N-6-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION

Effective date: 20250908

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251009

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-2-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20251209